Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    16967040 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Didanosine (enteric-coated);   Drug: Efavirenz;   Drug: Emtricitabine;   Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Lamivudine/Zidovudine
To Top

† Indicates status has not been verified in more than two years